News
Novo Nordisk ousts CEO
Digest more
"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
As Novo Nordisk's share price drops, CEO Lars Fruergaard Jorgensen steps down. The company aims to maintain its lead in the ...
Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback